Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Department of Radiology, Aalborg University Hospital, Aalborg, Denmark.
Semin Nucl Med. 2024 May;54(3):345-355. doi: 10.1053/j.semnuclmed.2023.11.003. Epub 2023 Dec 4.
This expedited systematic review aims to provide the first overview of the different Fibroblast activation protein inhibitor (FAPI) PET scan procedures in the literature and discuss how to efficiently obtain optimal FAPI PET images based on the best available evidence. The PubMed, Embase, Cochrane Library, and Web of Science databases were systematically searched in April 2023. Peer-reviewed cohort studies published in English and used FAPI tracers were included. Articles were excluded if critical scan procedure information was missing, or the article was not retrievable from a university library within 30 days. Data were grouped according to the FAPI tracer applied. Meta-analysis with proper statistics was deemed not feasible based on a pilot study. A total of 946 records were identified. After screening, 159 studies were included. [Ga]Ga-FAPI-04 was applied in 98 studies (61%), followed by [Ga]Ga-FAPI-46 in 19 studies (12%). Most studies did not report specific patient preparation. A mean/median administered activity of 80-200 MBq was most common; however, wide ranges were seen in [Ga]Ga-FAPI-04 PET studies (56-370 MBq). An injection-to-scan-time of 60 minutes was dominant for all FAPI PET studies. A possible trend toward shorter injection-to-scan times was observed for [Ga]Ga-FAPI-46. Three studies evaluated [Ga]Ga-FAPI-46 PET acquisition at multiple time points in more than 593 cancer lesions, all yielding equivalent tumor detection at 10 minutes vs later time points despite slightly lower tumor-to-background Ratios. Despite the wide ranges, most institutions administer an average of 80-200 MBq [Ga]Ga-FAPI-04/46 and scan patients at 60 minutes postinjection. For [Ga]Ga-FAPI-46, the present evidence consistently supports the feasibility of image acquisition earlier than 30 minutes. Currently, data on the optimal FAPI PET scan procedure are limited, and more studies are encouraged. The current review can serve as a temporary guideline for institutions planning FAPI PET studies.
这篇快速系统评价旨在对文献中不同的成纤维细胞激活蛋白抑制剂(FAPI)PET 扫描程序进行概述,并根据现有最佳证据讨论如何有效地获得最佳的 FAPI PET 图像。2023 年 4 月,系统检索了 PubMed、Embase、Cochrane 图书馆和 Web of Science 数据库。纳入了发表在英文期刊上并使用 FAPI 示踪剂的队列研究。如果关键扫描程序信息缺失或在 30 天内无法从大学图书馆获取文章,则将文章排除在外。根据应用的 FAPI 示踪剂对数据进行分组。根据试点研究,认为适当的统计学方法进行荟萃分析不可行。共确定了 946 条记录。经过筛选,纳入了 159 项研究。[Ga]Ga-FAPI-04 应用于 98 项研究(61%),其次是[Ga]Ga-FAPI-46 应用于 19 项研究(12%)。大多数研究未报告特定的患者准备情况。最常见的是给予 80-200MBq 的平均/中位数放射性活度;然而,[Ga]Ga-FAPI-04 PET 研究中观察到广泛的范围(56-370MBq)。所有 FAPI PET 研究中,注射至扫描时间为 60 分钟占主导地位。对于[Ga]Ga-FAPI-46,观察到注射至扫描时间缩短的可能趋势。三项研究在超过 593 个癌症病灶中评估了[Ga]Ga-FAPI-46 的多个时间点采集,尽管肿瘤与背景的比值略低,但所有研究均在 10 分钟与后期时间点检测到等效的肿瘤。尽管范围广泛,但大多数机构给予 80-200MBq 的[Ga]Ga-FAPI-04/46 平均剂量,并在注射后 60 分钟扫描患者。对于[Ga]Ga-FAPI-46,目前的证据一致支持在 30 分钟之前进行图像采集的可行性。目前,关于最佳 FAPI PET 扫描程序的数据有限,鼓励开展更多研究。本综述可为计划进行 FAPI PET 研究的机构提供临时指南。